Treatment for Anthracycline-Pretreated Breast Cancer

Treatment for Anthracycline-Pretreated Metastatic Breast Cancer Joyce O'Shaughnessy, Chris Twelves, Matti Aapro Oncologist 2002; 7(Suppl 6): 4-12 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Recognize the chemotherapy options that provide a survival benefit for anthracycline-pretreated metastatic breast cancer. Identify some of the validated treatment options for breast cancer patients with recurrent disease following anthracycline-based therapy. Explain the rationale for specific salvage treatment regimens in patients with recurrent breast cancer following anthracycline-based therapy. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: November 27, 2002 Most Recent Review: June 10, 2005* Most Recent Update: June 10, 2005 Date Credit Expires: Apr. 13, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.